Sigrid V. Carlsson, MD, PhD, MPH, presented “AI and Machine Learning: What the Future Holds” during the 27th Annual Southwest Prostate Cancer Symposium conference on October 17, 2024, in Scottsdale, Arizona.
How to cite: Carlsson, Sigrid V. “AI and Machine Learning: What the Future Holds.” October 17, 2024. Accessed Feb 2025. https://grandroundsinurology.com/ai-and-machine-learning-what-the-future-holds/
AI and Machine Learning: What the Future Holds – Summary
Sigrid V. Carlsson, MD, PhD, MPH, delves into the transformative potential of artificial intelligence (AI) and machine learning across various aspects of medicine and urology. She begins this 11-minute presentation by highlighting the broad applicability of large language models, such as ChatGPT, for tasks like scientific writing, coding, and summarizing articles. These tools prove particularly beneficial for non-native English speakers.
Dr. Carlsson emphasizes the importance of responsible AI use. Ethical concerns surrounding data privacy, plagiarism, and peer review confidentiality are discussed, underscoring the need for vigilance in scientific and clinical contexts.
Carlsson explores AI’s application in prostate MRI screening, pathology, and diagnostic accuracy. The technology is vital for standardizing care, addressing disparities, and enhancing health equity in underserved regions. Dr. Carlsson highlights the utility of AI in studying prostate cancer’s heterogeneous biology and touches on AI’s integration as a medical scribe, trial selection assistant, and simulator for surgical training.
About the 27th Annual Southwest Prostate Cancer Symposium:
Presented by Program Chairs Nelson N. Stone, MD, Richard G. Stock, MD, and William K. Oh, MD, this conference educated attendees about advances in the management of localized and advanced prostate cancer, with a focus on imaging, technology, and training in the related devices. It included a scientific session, as well as live demonstrations of surgical techniques. You can learn more about the conference here.
ABOUT THE AUTHOR
Sigrid V. Carlsson, MD, PhD, MPH, is Director of Clinical Research at Memorial Sloan Kettering Cancer Center’s (MSKCC) Josie Robertson Surgery Center and Assistant Attending Epidemiologist, with dual appointments in MSKCC’s Departments of Surgery (Urology Service) and Epidemiology and Biostatistics. Her line of research focuses on screening and early detection of prostate cancer, including multiplex testing and risk-stratified strategies that incorporate clinical information, biomarkers and magnetic resonance imaging, as recently funded by an NIH/NCI U01 award (PI: Carlsson).
Dr. Carlsson also serves as Associate Professor of Experimental Urology affiliated with the Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg University, in Sweden, where she is an investigator of two large randomized controlled trials of prostate cancer screening (GOTEBORG-1&2), as recently published in the New England Journal of Medicine (Hugosson J, et al. N Engl J Med 2022). In addition, Dr. Carlsson is Adjunct Senior Lecturer in the Department of Translational Medicine in the Division of Urological Cancers in the Medical Faculty at Lund University, Lund, Sweden.
Dr. Carlsson recently completed a K22 career development award from the NIH/NCI to improve shared decision-making for breast and prostate cancer screening. She serves on the National Comprehensive Cancer Network (NCCN) and is a panel member for the American Urological Association (AUA) guidelines for early detection of prostate cancer. Before pursuing postdoctoral studies in urologic oncology at MSKCC, Dr. Carlsson was a physician in Sweden. She earned her MD and PhD from Gothenburg University in Sweden and earned an MPH from Harvard TH Chan School of Public Health in Boston, Massachusetts.
